Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-05-29
2007-05-29
Saidha, Teckchand (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C530S350000, C530S399000, C536S023100
Reexamination Certificate
active
11035096
ABSTRACT:
The invention relates to assays for screening for chemicals which affect the binding between proteins comprising an SH3 binding motif (such as Proline-rich Nuclear Receptor Co-regulatory protein (PNRC)) and nuclear receptor proteins. Compounds which affect the binding of PNRC to nuclear receptors can affect the expression of genes whose expression is under the control of nuclear receptors to which PNRC binds. PNRC interacts with the orphan receptors SF1 and ERRα1 in a ligand-independent manner and interacts with the ligand-binding domains of nuclear receptors such as ER, AR, PR, TR, BAR, and RXR in a ligand-dependent manner. A 23-amino acid region in the carboxy-terminal proline-rich region which contains an SH3-binding motif is sufficient for the interaction with nuclear receptors.
REFERENCES:
Zhou et al. Gene. Nov. 21, 2005;361:89-100. Epub Sep. 21, 2005.
Agarwal, V.R. et al. “USe of Alternative Promoters to Express the Aromatase Cytochrome P450 (CYP19) Gene in Breast Adipose Tissues of Cancer-Free and Breast Cancer Patients”,J. Clin. Endocrinol. Metab., 1996; 81:3843-3849.
Bingle, C.D. “Generation of a Rat Bronchiolar Epithelial Cell cDNA Library: Isolation of a Proline Rich Protein Highly Enriched in Bronchiolar Epithelial Cells”,Biochemical and Biophysical Research Communications, 1996; 225:877-882.
Boulikas, T. “Nuclear Localization Signals (NLS)”,Critical Reviews in Eukaryotic Gene Expression, 1993; 3(3):193-227.
Cavaillès, V. et al. “Interaction of proteins with transcriptionally active estrogen receptors”,Proc. Natl. Acad. Sci. USA, Oct. 1994; 91:10009-10013.
Cavaillès, V. et al. “Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor”,The EMBO Journal, 1995; 14(15):3741-3751.
Chakravarti, D. et al. “Role of CBP/P300 in nuclear receptor signalling”,Nature, Sep. 5, 1996; 383:99-103.
Chen, J. et al. “Cloning a cDNA from human NK/T cells which codes for a protein with high proline content”,Biochimica et Biophysica Acta, 1995; 1264:19-22.
Ding, X.F. et al. “Nuclear Receptor-Binding Sites of Coactivators Glucocorticoid Receptor Interacting Protein 1 (Grip1) and Steroid Receptor Coactivator 1 (SRC-1): Multiple Motifs with Different Binding Specificities”,Molecular Endocrinology, 1998; 12:302-313.
Feng, S. et al. “Two Binding Orientations for Peptides to the Src SH3 Domain: Development of a General Model for SH3-Ligand Interactions”,Science, Nov. 18, 1994; 226:1241-1247.
Glass, C.K. et al. “Nuclear receptor coativators”,Current Opinion in Cell Biology, 1997; 9:222-232.
Halachmi, S. et al. “Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription”Science, Jun. 3, 1994; 264:1455-1458.
Hanstein, B. et al. “p300 is a component of an estrogen receptor coactivator complex”,Proc. Natl. Acad. Sci. USA, Oct. 1996; 93:11540-11545.
Harada, N. “Aberrant Expression of Aromatase in Breast Cancer Tissues”,J. Steroid Biochem. Molec. Biol., 1997; 61(3-6):175-184.
Heery, D.M. et al. “A signature motif in transcriptional co-activators mediates binding to nuclear receptors”,Nature, Jun. 12, 1997; 387-733-736.
Hong, H. et al. “GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors”,Proc. Natl. Acad. Sci. USA, May 1996; 93:4948-4952.
Horwitz, K.B. et al. “Nuclear Receptor Coactivators and Corepressors”,Molecular Endocrinology, 1996; 10:1167-1177.
Kamei, Y. et al. “A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors”,Cell, May 3, 1996; 85:403-414.
Le Douarin, B. et al. “The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in teh oncogenic protein T18”,The EMBO Journal, 1995; 14(9):2020-2033.
Lee, J.W. et al. “Interaction of thyroid-hormone receptor with a conserved trasncriptional mediator”,Nature, Mar. 2, 1995; 374:91-94.
Onate, S.A. et al. “Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily”,Science, Nov. 24, 1995; 270:1354-1357.
Pawson, T. “Protein modules and signalling networks”,Nature, Feb. 16, 1995; 373:573-580.
Shibata, H. et al. “Role of Co-activators and Co-repressors in the Mechanism of Steroid/Thyroid Receptor Action”,Recent Progress in Hormone Research, 1997; 52:141-165.
Suzuki, M. “SPXX, a Frequent Sequence Motif in Gene Regulatory Proteins”,J. Mol. Biol., 1989; 207:61-84.
Treuter, E. et al. “A Regulatory Role for RIP140 in Nuclear Receptor Activation”,Molecular Endocrinology, 1998; 12:864-881.
Voegel, J.J. et al. “TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors”,The EMBO Journal, 1996; 15(14):3667-3675.
vom Baur, E. et al. “Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1”,The EMBO Jouranl, 1996; 15(1):110-124.
Wang, J. et al. “Identification of a Promoter and a Silencer at the 3'-End of the First Intron of the Human Aromatase Gene”,Molecular Endocrinology, 1992; 6:1479-1488.
Williamson, M.P. “The structure and function of a proline-rich regions in proteins”,Biochem. J., 1994; 297:249-260.
Yang, C. et al. “Modulation of Aromatase Expression in the Breast Tissue by ERRα-1 Orphan Receptor”,Cancer Research; Dec. 15, 1998; 58:5695-5700.
Zhou, C. et al. “Aromatase Gene Expression and its Exon I Usage in Human Breast Tumors. Detection of Aromatase Messenger RNA by Reverse Transcription-polymerase Chain Reaction”,J. Steroid Biochem. Mol. Biol., 1996; 59(2):163-171.
Zhou, D. et al. “Characterization of a Silencer Element in the Human Aromatase Gene”,Archives of Biochemistry and Biophysics, May 15, 1998; 353(2):213-220.
Zhou, D. et al. “Identification and Characterization of a cAMP-Responsive Element in the Region Upstream from Promoter 1.3 of the Human Aromatase Gene”,Archives of Biochemistry and Biophysics, Nov. 15, 1999; 371(2):179-190.
Zhou, D. et al. “Identification of a Promoter That Controls Aromatase Expression in Human Breast Cancer And Adipose Stromal Cells”,The Journal of Biological Chemistry, Jun. 21, 1996; 271(25):15194-15202.
Jordan, V.C. “Targeted Antiestrogens to Prevent Breast Cancer,”Trends Endocrinol. Metab, 10(8):312-317, Oct. 1999.
Bentrem, D.J. et al., “Targeted Antiestrogens for the Prevention of Breast Cancer,”Oncol. Res., 11(9):401-107, 1999.
Levenson, A.S., “Selective Oestrogen Receptor Modulation: Molecular Pharmacology for the Millennium,”Eur. J. Cancer, 35(14):1974-1985, Dec. 1999.
Chen Shiuan
Zhou Dujin
City of Hope
Fronda Christian L.
Rothwell, Figg, Ernst & Manbeck pc
Saidha Teckchand
LandOfFree
Method of screening a chemical for binding to a proline-rich... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of screening a chemical for binding to a proline-rich..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening a chemical for binding to a proline-rich... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822465